ATC Group: L04AB03 Afelimomab

Anatomical Therapeutic Chemical Classification System

Translations

Language
Translation
  English
Afelimomab

Hierarchical Position

Active Ingredients

Chemical substance
Description

Afelimomab is an anti-TNFα monoclonal antibody. Administration of afelimomab reduces the concentration of interleukin-6 in patients with sepsis, but reduces mortality only marginally.